Log in or Sign up for Free to view tailored content for your specialty!
Geriatrics News
Transcranial direct stimulation improves anomia in dementia
Transcranial direct current stimulation improved picture recognition among individuals with Alzheimer’s disease or frontotermporal dementia, according to findings presented at the American Academy of Neurology Annual Meeting.
Severe Impairment Battery effective for Alzheimer's disease
Findings presented at the American Academy of Neurology showed accuracy of quantitatively-derived Severe Impairment Battery composite scores for individuals with moderate-to-severe or severe Alzheimer’s disease.
Log in or Sign up for Free to view tailored content for your specialty!
Nursing home training program associated with reduction of antipsychotic use
Training nursing home staff to anticipate resident needs can decrease the use of antipsychotics for the treatment of dementia; however, training reinforcement is needed to sustain the decreases, according to findings published in JAMA Internal Medicine.
Rivastigmine plus citalopram comparable to rivastigmine for depression in Alzheimer’s
Rivastigmine plus citalopram did not have superior efficacy compared with rivastigmine alone among individuals with Alzheimer’s disease, according to data presented at the American Academy of Neurology annual meeting.
Adjunctive memantine reduces agitation in Alzheimer's disease
Memantine plus cholinesterase inhibitors reduced agitation, delusion and other behavioral symptoms in individuals with Alzheimer’s disease, according to data presented at the American Academy of Neurology annual meeting.
Mental, behavioral disorders do not increase Alzheimer’s disease risk
Analysis of national data indicated modest and time-dependent associations between mental and behavioral disorders and increased risk for Alzheimer’s disease.
Vascular risk factors increase risk for Alzheimer's disease
Recent findings indicated a higher number of midlife vascular risk factors, such as diabetes and higher BMI, was associated with increased risk for brain amyloid deposition, a marker of Alzheimer’s disease.
Benzodiazepines associated with increased risk for pneumonia in Alzheimer’s disease
Benzodiazepines, a class of commonly used sedatives, were linked with an increased risk for pneumonia among patients with Alzheimer disease, according to findings from a newly published study from Finland.
FDA authorizes marketing of personal genetic risk tests
The FDA authorized marketing of 23andMe Personal Genome Service Genetic Health Risk tests for 10 diseases and conditions, including Alzheimer’s disease, Parkinson’s disease and celiac disease.
Polygenic risk scores predict Alzheimer disease risk
Recent findings indicated utility of polygenic risk scores for determining individual differences in age-specific genetic risk for Alzheimer disease.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read